
Rebecca Robbins
Reporter at The New York Times
@nytimes reporter covering prescription drugs [email protected] 714-478-4224 for calls, texts, Signal or WhatsApp
Articles
-
3 weeks ago |
nytimes.com | Rebecca Robbins
Novo Nordisk will replace its chief executive, Lars Fruergaard Jorgensen, the company announced Friday, citing a sharp decline in its stock price that stemmed from increased competition for its popular weight-loss drug. The Danish drugmaker said it was searching for a new chief executive to soon replace Mr. Jorgensen, who has led Novo Nordisk for eight years.
-
3 weeks ago |
businessandamerica.com | Rebecca Robbins |Reed Abelson
Tens of thousands of Americans will soon be forced by their health insurance to switch from one popular obesity drug to another that produces less weight loss. It is the latest example of the consequences of secret deals between drugmakers and middlemen, known as pharmacy benefit managers, that are hired by employers to oversee prescription coverage for Americans.
-
3 weeks ago |
seattletimes.com | Reed Abelson |Rebecca Robbins
Tens of thousands of Americans will soon be forced by their health insurance to switch from one popular obesity drug to another that produces less weight loss. It is the latest example of the consequences of secret deals between drugmakers and middlemen, known as pharmacy benefit managers, that are hired by employers to oversee prescription coverage for Americans.
-
3 weeks ago |
nytimes.com | Margot Sanger-Katz |Rebecca Robbins
The president has long complained that the United States pays more for medicines than other wealthy countries. But he offered no clear legal authority to mandate lower prices. President Trump on Monday signed an executive order asking drugmakers to voluntarily reduce the prices of key medicines in the United States. But the order cites no obvious legal authority to mandate lower prices.
-
3 weeks ago |
businessandamerica.com | Rebecca Robbins |Margot Sanger-Katz
President Trump will sign an executive order on Monday aimed at lowering some drug prices in the United States by aligning them with what other wealthy countries pay, he said on Truth Social on Sunday evening. The proposal he described, which alone cannot shift federal policy, is what he calls a “most favored nation” pricing model.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 23K
- Tweets
- 26
- DMs Open
- Yes

New: @ChrisDHamby is out today with the 3rd story in the New York Times' series on PBMs. His reporting, based on hundreds of documents, shows how PBMs took secret payments from manufacturers to allow free flow of opioids. https://t.co/VMBdct2pjO